Table 2.
Baseline characteristics of HBV-related chronic inflammation demyelinating polyneuropathy
| Case 17,8 | Case 213 | Case 312 | Case 414 | Case 515 | |
| Age (yr) | 60 | 60 | 39 | 44 | 57 |
| Sex | Female | Male | Male | Male | Male |
| Etiology | HBV | HBV | HBV | HBV | HBV |
| HCV | Hantavirus | ||||
| Cirrhosis | Compensated | Compensated | No | No | No |
| HBV-DNA (IU/mL) | N/A | N/A | 8.5 × 106 | N/A | N/A |
| Therapy | N/A | IVIG | IVIG | Prednisolone | IVIG |
| Tenofovir | Azathioprine | Entecavir | |||
| Methylprednisolone | |||||
| Outcome | N/A | Improved | Improved | Improved | Improved |
| Follow-up (wk) | N/A | 4 | 24 | 32 | 52 |
HBV, hepatitis B virus; HCV, hepatitis C virus; IVIG, intravenous immunoglobulin; N/A, not applicable.